Logo image of BCBP

BCB BANCORP INC (BCBP) Stock Fundamental Analysis

NASDAQ:BCBP - Nasdaq - US0552981039 - Common Stock - Currency: USD

9.88  0 (0%)

After market: 9.88 0 (0%)

Fundamental Rating

4

BCBP gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 402 industry peers in the Banks industry. BCBP may be in some trouble as it scores bad on both profitability and health. BCBP is not valued too expensively and it also shows a decent growth rate. BCBP also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

In the past year BCBP was profitable.
In the past year BCBP had a positive cash flow from operations.
In the past 5 years BCBP has always been profitable.
BCBP had a positive operating cash flow in 4 of the past 5 years.
BCBP Yearly Net Income VS EBIT VS OCF VS FCFBCBP Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M

1.2 Ratios

Looking at the Return On Assets, with a value of 0.55%, BCBP is doing worse than 69.80% of the companies in the same industry.
With a Return On Equity value of 6.06%, BCBP is not doing good in the industry: 67.57% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA 0.55%
ROE 6.06%
ROIC N/A
ROA(3y)0.83%
ROA(5y)0.86%
ROE(3y)9.91%
ROE(5y)9.93%
ROIC(3y)N/A
ROIC(5y)N/A
BCBP Yearly ROA, ROE, ROICBCBP Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

BCBP has a worse Profit Margin (20.08%) than 61.14% of its industry peers.
In the last couple of years the Profit Margin of BCBP has declined.
The Operating Margin and Gross Margin are not available for BCBP so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) 20.08%
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-17.24%
PM growth 5Y-4.61%
GM growth 3YN/A
GM growth 5YN/A
BCBP Yearly Profit, Operating, Gross MarginsBCBP Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10 20 30

3

2. Health

2.1 Basic Checks

BCBP does not have a ROIC to compare to the WACC, probably because it is not profitable.
BCBP has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, BCBP has less shares outstanding
The debt/assets ratio for BCBP is higher compared to a year ago.
BCBP Yearly Shares OutstandingBCBP Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
BCBP Yearly Total Debt VS Total AssetsBCBP Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

BCBP has a debt to FCF ratio of 1.12. This is a very positive value and a sign of high solvency as it would only need 1.12 years to pay back of all of its debts.
BCBP has a Debt to FCF ratio of 1.12. This is in the better half of the industry: BCBP outperforms 75.00% of its industry peers.
BCBP has a Debt/Equity ratio of 0.20. This is a healthy value indicating a solid balance between debt and equity.
BCBP has a Debt to Equity ratio (0.20) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 1.12
Altman-Z N/A
ROIC/WACCN/A
WACC12.82%
BCBP Yearly LT Debt VS Equity VS FCFBCBP Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.3 Liquidity

Industry RankSector Rank
Current Ratio N/A
Quick Ratio N/A
BCBP Yearly Current Assets VS Current LiabilitesBCBP Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M

4

3. Growth

3.1 Past

The earnings per share for BCBP have decreased strongly by -28.24% in the last year.
BCBP shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 0.16% yearly.
The Revenue for BCBP has decreased by -12.20% in the past year. This is quite bad
BCBP shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 1.53% yearly.
EPS 1Y (TTM)-28.24%
EPS 3Y-14.03%
EPS 5Y0.16%
EPS Q2Q%-34.29%
Revenue 1Y (TTM)-12.2%
Revenue growth 3Y-3.63%
Revenue growth 5Y1.53%
Sales Q2Q%-14.8%

3.2 Future

The Earnings Per Share is expected to grow by 16.31% on average over the next years. This is quite good.
BCBP is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 7.92% yearly.
EPS Next Y-3.24%
EPS Next 2Y16.31%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.06%
Revenue Next 2Y7.92%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BCBP Yearly Revenue VS EstimatesBCBP Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 20M 40M 60M 80M 100M
BCBP Yearly EPS VS EstimatesBCBP Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.5 1 1.5 2 2.5

6

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 8.10, the valuation of BCBP can be described as reasonable.
Based on the Price/Earnings ratio, BCBP is valued cheaply inside the industry as 91.34% of the companies are valued more expensively.
When comparing the Price/Earnings ratio of BCBP to the average of the S&P500 Index (29.35), we can say BCBP is valued rather cheaply.
Based on the Price/Forward Earnings ratio of 8.37, the valuation of BCBP can be described as reasonable.
Based on the Price/Forward Earnings ratio, BCBP is valued cheaply inside the industry as 86.14% of the companies are valued more expensively.
When comparing the Price/Forward Earnings ratio of BCBP to the average of the S&P500 Index (22.10), we can say BCBP is valued rather cheaply.
Industry RankSector Rank
PE 8.1
Fwd PE 8.37
BCBP Price Earnings VS Forward Price EarningsBCBP Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Price/Free Cash Flow ratio, BCBP is valued cheaply inside the industry as 96.53% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 2.8
EV/EBITDA N/A
BCBP Per share dataBCBP EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15

4.3 Compensation for Growth

A more expensive valuation may be justified as BCBP's earnings are expected to grow with 16.31% in the coming years.
PEG (NY)N/A
PEG (5Y)49.16
EPS Next 2Y16.31%
EPS Next 3YN/A

8

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 6.48%, BCBP is a good candidate for dividend investing.
In the last 3 months the price of BCBP has falen by -23.53%. A price decline artificially increases the dividend yield. It may be a sign investors do not expect the dividend to last.
BCBP's Dividend Yield is rather good when compared to the industry average which is at 3.37. BCBP pays more dividend than 95.05% of the companies in the same industry.
BCBP's Dividend Yield is rather good when compared to the S&P500 average which is at 2.33.
Industry RankSector Rank
Dividend Yield 6.48%

5.2 History

The dividend of BCBP has a limited annual growth rate of 1.62%.
BCBP has been paying a dividend for at least 10 years, so it has a reliable track record.
BCBP has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)1.62%
Div Incr Years0
Div Non Decr Years17
BCBP Yearly Dividends per shareBCBP Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

59.97% of the earnings are spent on dividend by BCBP. This is a bit on the high side, but may be sustainable.
BCBP's earnings are growing more than its dividend. This makes the dividend growth sustainable.
DP59.97%
EPS Next 2Y16.31%
EPS Next 3YN/A
BCBP Yearly Income VS Free CF VS DividendBCBP Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
BCBP Dividend Payout.BCBP Dividend Payout, showing the Payout Ratio.BCBP Dividend Payout.PayoutRetained Earnings

BCB BANCORP INC

NASDAQ:BCBP (3/7/2025, 8:06:54 PM)

After market: 9.88 0 (0%)

9.88

0 (0%)

Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupBanks
GICS IndustryBanks
Earnings (Last)01-28 2025-01-28/bmo
Earnings (Next)04-17 2025-04-17/bmo
Inst Owners39.4%
Inst Owner Change-0.47%
Ins Owners11.97%
Ins Owner Change1.66%
Market Cap168.55M
Analysts78
Price Target13.45 (36.13%)
Short Float %0.65%
Short Ratio1.69
Dividend
Industry RankSector Rank
Dividend Yield 6.48%
Yearly Dividend0.66
Dividend Growth(5Y)1.62%
DP59.97%
Div Incr Years0
Div Non Decr Years17
Ex-Date02-07 2025-02-07 (0.16)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)5.53%
Min EPS beat(2)-2.57%
Max EPS beat(2)13.62%
EPS beat(4)1
Avg EPS beat(4)-1.61%
Min EPS beat(4)-8.98%
Max EPS beat(4)13.62%
EPS beat(8)1
Avg EPS beat(8)-10.24%
EPS beat(12)5
Avg EPS beat(12)-3.05%
EPS beat(16)9
Avg EPS beat(16)4%
Revenue beat(2)2
Avg Revenue beat(2)1.58%
Min Revenue beat(2)0.9%
Max Revenue beat(2)2.25%
Revenue beat(4)3
Avg Revenue beat(4)0.45%
Min Revenue beat(4)-2.12%
Max Revenue beat(4)2.25%
Revenue beat(8)3
Avg Revenue beat(8)-5.16%
Revenue beat(12)5
Avg Revenue beat(12)-4%
Revenue beat(16)8
Avg Revenue beat(16)-1.79%
PT rev (1m)-7.46%
PT rev (3m)-4.95%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-18.58%
EPS NY rev (3m)-20.03%
Revenue NQ rev (1m)-0.01%
Revenue NQ rev (3m)-0.01%
Revenue NY rev (1m)-1.19%
Revenue NY rev (3m)-0.87%
Valuation
Industry RankSector Rank
PE 8.1
Fwd PE 8.37
P/S 1.7
P/FCF 2.8
P/OCF 2.78
P/B 0.51
P/tB 0.52
EV/EBITDA N/A
EPS(TTM)1.22
EY12.35%
EPS(NY)1.18
Fwd EY11.95%
FCF(TTM)3.52
FCFY35.66%
OCF(TTM)3.55
OCFY35.95%
SpS5.8
BVpS19.23
TBVpS18.93
PEG (NY)N/A
PEG (5Y)49.16
Profitability
Industry RankSector Rank
ROA 0.55%
ROE 6.06%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 20.08%
GM N/A
FCFM 60.72%
ROA(3y)0.83%
ROA(5y)0.86%
ROE(3y)9.91%
ROE(5y)9.93%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-17.24%
PM growth 5Y-4.61%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.03
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 1.12
Debt/EBITDA N/A
Cap/Depr 27.78%
Cap/Sales 0.51%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality 302.4%
Current Ratio N/A
Quick Ratio N/A
Altman-Z N/A
F-Score4
WACC12.82%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-28.24%
EPS 3Y-14.03%
EPS 5Y0.16%
EPS Q2Q%-34.29%
EPS Next Y-3.24%
EPS Next 2Y16.31%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-12.2%
Revenue growth 3Y-3.63%
Revenue growth 5Y1.53%
Sales Q2Q%-14.8%
Revenue Next Year6.06%
Revenue Next 2Y7.92%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1YN/A
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y58.16%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y42.25%
OCF growth 3YN/A
OCF growth 5YN/A